Asset Publisher

< Back to Blue Advantage Final Medical Policies page

Final Policies: O - S

Policy # Policy Title View
BA-022 Occlusion of Uterine Arteries Using Transcatheter Embolization or Laparoscopic Occlusion to Treat Uterine Fibroids
BA-337 Oncologic Applications of Photodynamic Therapy, Including Barrett’s Esophagus
BA-631 Open and Thoracoscopic Approaches to Treat Atrial Fibrillation and Atrial Flutter (Maze and Related Procedures)
BA-465 Ophthalmologic Techniques That Evaluate the Posterior Segment for Glaucoma
BA-248 Osteochondral Autografts and Allografts in the Treatment of Focal Articular Cartilage Lesions
BA-454 Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux
BA-301 Phototherapy for the Treatment of Skin Disorders
BA-187 Pulsed Dye Laser Treatment of Recalcitrant Verrucae
BA-119 Radiofrequency Ablation of Solid Tumors Excluding Liver Tumors
BA-574 Responsive Neurostimulation for the Treatment of Refractory Focal Epilepsy
BA-174 Risk-Reducing Mastectomy
BA-452 Scintimammography and Gamma Imaging of the Breast and Axilla
BA-723 Screening Magnetic Resonance Imaging (MRI) for Evaluation of Breast Implant Integrity in Asymptomatic Individuals
BA-161 Serologic Diagnosis of Celiac Disease
BA-346 Stretching and Splinting Devices for the Treatment of Joint Stiffness and Contractures
BA-312 Suprachoroidal Delivery of Pharmacological Agents
BA-421 Surgical Treatment of Femoroacetabular Impingement
BA-735 Sustained-Release Intracameral Glaucoma Therapy Policy